secwatch.observer — SEC 8-K summary
======================================

Issuer:     OnKure Therapeutics, Inc. (OKUR)
CIK:        0001637715
Form:       8-K
Filed at:   2022-06-02T23:59:59+00:00
Accession:  0001558370-22-009679
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Reneo shareholders elect Dube and Hoelscher as Class I directors, ratify Ernst & Young as auditor
--------------------------------------------------------------------------------

- Annual Meeting held June 1, 2022; total outstanding shares 24,458,550.
- Eric M. Dube elected with 18,100,489 votes for, 795,195 against, 2,790,889 broker non-votes.
- Paul W. Hoelscher elected with 18,877,021 votes for, 18,663 against, 2,790,889 broker non-votes.
- Ratification of Ernst & Young as independent auditor for fiscal 2022 approved (21,675,242 for, 11,300 against).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1637715/000155837022009679/0001558370-22-009679-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1637715/000155837022009679/rphm-20220601x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-22-009679

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer